Bpx

Latest News for: bpx

Edit

BPX Appointed as Schneider Electric Alliance Master Partner in Industrial Automation Distribution

Process and Control Today 14 May 2021

BPX Appointed as Schneider Electric Alliance Master Partner in Industrial Automation Distribution ... The appointment is recognition of the level of expertise BPX holds in the industrial integration of Schneider Electric systems ... Find out more details on the Schneider Electric and BPX IAD programme status here.

Edit

BPX Energy is bringing drilling rigs back to Texas

Business Journal 08 Feb 2021

“The rocks look really, really good — better than we had hoped,” BP CEO Bernard Looney said of the company's drilling plans in Texas ... .

Edit

Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial (Bellicum Pharmaceuticals Inc)

Public Technologies 29 Jan 2021

'I remain optimistic about the safety and potential clinical benefit of our BPX-601 product candidate in these patients.'. About BPX-601 ... Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.

Edit

Bellicum Reports FDA Lifted Clinical Hold on BPX-601�Phase 1/2 Clinical Trial

Nasdaq Globe Newswire 28 Jan 2021

Food and Drug Administration (FDA) has lifted the clinical hold on patient enrollment and ...

Edit

Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603

Nasdaq Globe Newswire 10 Dec 2020

... trial for BPX-603 in patients with tumors that express human epidermal growth factor 2 (HER2).

Edit

Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603 (Bellicum Pharmaceuticals Inc)

Public Technologies 10 Dec 2020

BPX-603 is Bellicum's first dual switch GoCAR-T® product candidate that incorporates the company's iMC activation and CaspaCIDe® safety switch technologies ... About BPX-603 ... Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.

Edit

Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial

Nasdaq Globe Newswire 07 Dec 2020

The clinical investigator and Bellicum classified the patient death as unrelated to BPX-601 and rimiducid.

Edit

Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial (Bellicum Pharmaceuticals Inc)

Public Technologies 07 Dec 2020

The clinical investigator and Bellicum classified the patient death as unrelated to BPX-601 and rimiducid ... About BPX-601 ... Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.

Edit

Bellicum Announces Interim BPX-601 Data and Corporate Restructuring

Nasdaq Globe Newswire 29 Oct 2020

... its BPX-601 dose-escalation clinical trial in patients with relapsed/refractory metastatic pancreatic cancer.

Edit

Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04

Nasdaq Globe Newswire 15 Sep 2020

- Formal notice confirms intent to grant patent for pharmaceutical tetracycline compositions for dermatological use - ... .

Edit

Timber Pharmaceuticals Announces European Patent Office Intends to Grant Patent for BPX-01 and BPX-04

Nasdaq Globe Newswire 22 Jul 2020

�Stable topical composition has potential to reduce side effects of orally delivered compositions in treatment of acne and rosacea� ... .

Edit

Drahos, BPX Team Up for Shakespeare Summer Camp

The Pilot 11 Jul 2020

When it comes to theater arts, Dr. Jonathan Drahos, an associate professor in theater at UNCP, and Joe Brown, executive director of BPAC, have a common commitment. To keep theater alive for Moore County youth in the age of COVID. So when they designed “Shakespeare and Me. The Pseudo-Virtual Summer Camp for Teens,” they managed to honor Gov ... .

Edit

Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a ...

Nasdaq Globe Newswire 15 Jun 2020

Food and Drug Administration (FDA) of its investigational new drug application (IND) for BPX-603. BPX-603 is a GoCAR-T® ...

Edit

Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid Tumors

Public Technologies 15 Jun 2020

Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms ... we will be able to manufacture BPX-603 in compliance with cGMPs for use in the planned clinical trials.

Edit